FULVICIN P Drug Patent Profile
✉ Email this page to a colleague
When do Fulvicin P patents expire, and what generic alternatives are available?
Fulvicin P is a drug marketed by Chartwell Rx and is included in one NDA.
The generic ingredient in FULVICIN P is griseofulvin, ultramicrosize. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the griseofulvin, ultramicrosize profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fulvicin P
A generic version of FULVICIN P was approved as griseofulvin, ultramicrosize by MOUNTAIN on January 9th, 2014.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FULVICIN P?
- What are the global sales for FULVICIN P?
- What is Average Wholesale Price for FULVICIN P?
Summary for FULVICIN P
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | FULVICIN P at DailyMed |
